Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07824167) titled 'The EMBRACE Study: Enflonsia Monoclonal in Babies - RSV Antibody Concentration Evaluation' on Sept. 11.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Basic Science. Masking: None (Open Label).
Primary Sponsor: Emory University
Condition:
RSV Infection
Intervention:
Biological: Clesrovimab
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: September 2026
Target Sample Size: 24
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07824167
Disclaimer: Curated by ...